PRPO supply chain intelligence for Precipio, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Precipio, Inc. (PRPO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ONE-CUSTOMER | ONE-CUSTOMER | 92% | At December 31, 2024, one customer accounted for approximately 29% of our total accounts receivable. |
| THREE-CUSTOMERS | THREE-CUSTOMERS | 92% | At December 31, 2025, we had three customers who each individually represented more than 10% of our total accounts receivable. |
| MYGN | Myriad Genetics, Inc. | 72% | Reciprocal relationship from MYGN graph: Reciprocal relationship from PRPO graph: to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to pr… |
| MYGN | Myriad Genetics, Inc. | 72% | to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or in… |
| SNYNF | Sanofi | 72% | to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or in… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from PRPO graph: to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to p… |
| UNH | UnitedHealth Group Incorporated | 62% | Reciprocal relationship from UNH graph: Reciprocal relationship from PRPO graph: e as follows: 2026 2027 2028 Total DECD loan $ 33 $ 34 $ 16 … |
| UNITEDHEALTH-GROUP | UNITEDHEALTH-GROUP | 62% | e as follows: 2026 2027 2028 Total DECD loan $ 33 $ 34 $ 16 $ 83 6 . ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES. Accrued expenses a… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| PRPO-DEBT-11904 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2020-12-31. |
| PRPO-DEBT-11903 | Warrants outstanding: 10000 | 90% | xbrl warrant detail from xbrl 2026-03-31. |
| PRPO-DEBT | Debt stack $325,000 | 90% | Market cache reports total debt of $325,000. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| ATOS | Atossa Therapeutics, Inc. | 100.00 | 2 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 100.00 | 2 | |
| PSNL | Personalis, Inc. | 100.00 | 2 | |
| EDIT | Editas Medicine, Inc. | 100.00 | 2 | |
| ANRO | Alto Neuroscience, Inc. | 100.00 | 2 | |
| BNTC | Benitec Biopharma Inc. | 100.00 | 2 | |
| SVA | Sinovac Biotech Ltd. | 100.00 | 2 | |
| BLRX | BioLineRx Ltd. | 100.00 | 2 | |
| DBVTF | DBV TECHNOLOGIES | 100.00 | 2 | |
| BIOA | BioAge Labs, Inc. | 100.00 | 2 | |
| CYTK | Cytokinetics, Incorporated | 100.00 | 2 | |
| CBIO | Crescent Biopharma, Inc. | 100.00 | 2 | |
| BNBX | BNB Plus Corp. | 100.00 | 2 | |
| ALXO | ALX Oncology Holdings Inc. | 100.00 | 2 | |
| CYTOF | Altamira Therapeutics Ltd. | 100.00 | 2 | |
| CCEP | Coca-Cola Europacific Partners PLC | 100.00 | 2 | |
| DSGN | Design Therapeutics, Inc. | 100.00 | 2 | |
| AZN | AstraZeneca PLC | 100.00 | 2 | |
| ANL | Adlai Nortye Ltd. | 100.00 | 2 | |
| CALC | CalciMedica, Inc. | 100.00 | 2 |